Major Portfolio Companies
Life Sciences, Consumer & Real Estate
Back to previous data
View more data
|
|
Market
Capitalisation
or Shareholder Equity1 |
|
Key
figures2 |
|
|
|
|
|
|
Revenue |
|
PATMI |
|
Shareholding (%)
as at 31 Mar 11 |
Currency |
2010 |
2011 |
|
FY 2009 |
FY 2010 |
|
FY 2009 |
FY 2010 |
 |
13 |
SGD’m |
5,230 |
5,965 |
|
8,588 |
10,455 |
|
252 |
359 |
 |
39 |
SGD’m |
16,901 |
14,087 |
|
2,957 |
3,383 |
|
1,053 |
1,273 |
 |
3 |
HKD’m |
144,634 |
160,708 |
|
104,479 |
124,115 |
|
3,369 |
4,278 |
 |
100 |
SGD’m |
5,095 |
5,825 |
|
453 |
590 |
|
394 |
747 |
 |
43 |
SGD’m |
2,897 |
2,780 |
|
1,539 |
1,729 |
|
181 |
191 |
 |
100 |
SGD’m |
505 |
544 |
|
266 |
281 |
|
60 |
56 |
 |
88 |
SGD’m |
148 |
162 |
|
91 |
102 |
|
17 |
14 |
|
|
Key figures2 |
|
TSR3 (%) |
|
|
EVA |
|
Change in EVA |
|
Years |
|
|
FY 2009 |
FY 2010 |
|
FY 2009 |
FY 2010 |
|
1 |
3 |
5 |
 |
|
124* |
13 |
|
NA |
(111) |
|
8.9 |
11.8 |
12.5 |
 |
|
(568) |
(506) |
|
(57) |
62 |
|
(14.6) |
(12.3) |
(1.5) |
 |
|
1,091 |
1,605 |
|
208 |
514 |
|
6.8 |
14.1 |
23.2 |
 |
|
284 |
469 |
|
783 |
185 |
|
14.8 |
10.1 |
19.9 |
 |
|
67 |
68 |
|
NA |
1 |
|
(0.9) |
9.0 |
7.0 |
 |
|
46 |
40 |
|
(14) |
(6) |
|
9.7 |
23.4 |
24.8 |
 |
|
5 |
5 |
|
– |
– |
|
9.4 |
12.5 |
15.3 |
Sources:
Footnotes:
Back to top